US Physiological Saline Market is expected to reach US$ 3,910.28 million by 2030

According to our new research study on “US Physiological Saline Market Forecast to 2030 –Country Analysis – by Type, Packaging Type, Application, Route of Administration, and End User,” the market is expected to grow from US$ 2,412.58 million in 2022 to US$ 3,910.28 million by 2030; it is estimated to record a CAGR 6.2% during 2022–2030. The rising prevalence of serious illnesses and fluid electrolyte disorders, and surging demand for fluid electrolytes in the aging population are among the key factors driving the US physiological saline market growth. However, adverse effects of rapid isotonic saline infusion restrict the growth of the market.

A physiological saline solution consist of salt solutions that are isotonic and have the same pH. For example, the Ringer's solution is composed of a mixture of sodium chloride (NaCl), sodium bicarbonate, and potassium chloride. The physiological solution is recommended by physicians in case of dehydration, fluid imbalances, and many more clinical abnormalities. 

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00032155

Surging Demand for Fluid Electrolytes in Aging Population Bolsters US Physiological Saline Market

As per the Urban Institute report, the number of Americans aged 65 years and older would reach 80 million by 2040. By 2040, nearly 20% of Americans are likely to be aged 65 years or older. With aging, the dependency on fluid electrolytes would also increase as aging results in decreased glomerular filtration rate (GFR) and urinary concentrating ability as well as narrowed limits for the excretion of water, sodium, potassium, and acid. Additionally, total body water decreases with age. For example, by the age of 80, the water levels reduce by almost 50%, resulting in less arterial distensibility, decreasing baroreceptor reflexes, and sluggish hemostatic mechanisms. These alterations lead to increased susceptibility to hemodynamic changes among the elderly. Therefore, physicians need to understand the hemostatic changes that occur among elderly patients while treating the aging population. Therefore, the rising aging population, which is highly prone to fluid imbalance, propels the US physiological saline market.

Market Opportunity

Rapid Sample Transportation Using Low-Cost Saline Solutions

A less expensive and readily available saline solution can be used for the safe transportation of testing samples, enabling more effective, long-distance transportation of samples to diagnostic labs. A readily available saline solution such as "Phosphate Buffered Saline," a simple salt solution commonly available in hospitals and clinical laboratories, was in use as a transport medium for coronavirus-contaminated specimens; the saline could keep the samples stable for up to 18 hours. During the COVID-19 pandemic, a shortage of viral transport media posed a major challenge in the transportation of specimens obtained from COVID-19 patients to diagnostics and testing labs, which resulted in an upsurge in the demand for sterile saline solutions. As a result, researchers recommended using inexpensive and commonly available salt solutions, such as phosphate-buffered saline solutions, for transportation. Therefore, the rising awareness of less expensive and readily available saline solutions, and their use in the transportation of medical specimens is likely to provide opportunities to the US physiological saline market during 2022–2030.

US Physiological Saline Market: Competitive Landscape and Key Developments

Fresenius Kabi AG, Merck KGaA, AdipoGen Life Sciences Inc, Enzo Life Sciences Inc, ICU Medical Inc, Grifols SA, Geno Technology Inc, B Braun Medical Inc, Pfizer Inc, and Ward's Science are among the major players in the US physiological saline market. Leading players adopt strategies such as the launch of new products, expansion and diversification of their market presence, and expansion of new customer base for tapping prevailing business opportunities.

The report segments the US Physiological Saline market as follows:

The US physiological saline market, by type, is segmented into normal saline, hypertonic saline, hypotonic saline, and balanced saline. The normal saline segment held the largest market share in 2022. However, the hypertonic saline segment is expected to register the highest CAGR during the forecast period. The US physiological saline market, by packaging type, is segmented into flexible bags, plastic bottles, and glass bottles. The plastic bottles segment held the largest market share in 2022. The flexible bag segment is anticipated to register the highest CAGR during 2022-2030. The US physiological saline market, by application, is segmented as intravenous, ophthalmology, wound care, endoscopy, skin abrasion, and others. The intravenous segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022-2030. The US physiological saline market, by route of administration, is categorized into intravenous and topical. The intravenous segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022-2030. The US physiological saline market, by end user, is segmented into hospitals, specialty clinics, ambulatory surgical centers, home care, and others. The hospitals segment held the largest market share in 2022. The specialty clinics segment is anticipated to register the highest CAGR during 2022-2030.

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com